← Open Payments lookup

LOUISE MUHOZI: Open Payments

NPI 1114305331 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,407 in 269 payments from 13 companies in 2025. Trend: 2023 $2,607 · 2024 $3,379 · 2025 $3,407

Food & beverage: $3,387Education: $20
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.29$433
ABBVIE INC.37$398
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)28$392
Otsuka America Pharmaceutical, Inc.26$346
Alkermes, Inc.19$343
Neurocrine BioSciences, Inc.20$341
Vanda Pharmaceuticals Inc.41$298
Janssen Pharmaceuticals, Inc11$256
Axsome Therapeutics, Inc.17$225
Teva Pharmaceuticals USA, Inc.19$180

Products named: COBENFY, VRAYLAR, CAPLYTA, INGREZZA, REXULTI, ARISTADA, INVEGA SUSTENNA, HETLIOZ.

Industry payments across KS — which companies pay providers there.